Meriden, Conn.-based Protein Sciences is becoming well known for its Ebola vaccine. Although the company has been in business for 31 years, it has been capturing attention lately for one of its vaccines that is already available (Flublok) and another that is in development, according to an article in The Middletown Press.
The vaccine in development prevents the spread of the Ebola virus, and it received a lot of attention in October when Americans’ fear of catching the disease was at its height. Protein Sciences expects to submit its Ebola vaccine to the National Institutes of Health (NIH) by the end of the year. Read the full story
